Rein Therapeutics Publishes Study On Anti-Fibrotic Effects Of LTI-2355 In IPF And COVID-Related Fibrosis

Benzinga · 04/15 11:06

Manuscript highlights the effects of caveolin scaffolding domain peptide LTI-2355 on myeloid cell activity in Idiopathic Pulmonary Fibrosis (IPF) and Post-Acute Sequelae of COVID Fibrosis (PASC-F)